BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6382033)

  • 1. Phenytoin in IgA nephropathy: a long-term controlled trial.
    Egido J; Rivera F; Sancho J; Barat A; Hernando L
    Nephron; 1984; 38(1):30-9. PubMed ID: 6382033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of phenytoin therapy in IgA nephropathy.
    Clarkson AR; Seymour AE; Woodroffe AJ; McKenzie PE; Chan YL; Wootton AM
    Clin Nephrol; 1980 May; 13(5):215-8. PubMed ID: 6994960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy.
    Mustonen J; Pasternack A; Helin H; Rilva A; Penttinen K; Wager O; Harmoinen A
    Nephron; 1981; 29(3-4):170-5. PubMed ID: 7329493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.
    Trascasa ML; Egido J; Sancho J; Hernando L
    Clin Exp Immunol; 1980 Nov; 42(2):247-54. PubMed ID: 6781799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of levels of circulating IgA-class immune complex in discriminant analysis of patients with IgA nephropathy before renal biopsy.
    Yagame M; Suzuki D; Watanabe K; Nakao E; Eguchi K; Miyazaki M; Matsumoto Y; Yano N; Kuramoto T; Sakai H
    Nephron; 1991; 57(4):433-8. PubMed ID: 2046826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum complement proteins in IgA nephropathy.
    Julian BA; Wyatt RJ; McMorrow RG; Galla JH
    Clin Nephrol; 1983 Nov; 20(5):251-8. PubMed ID: 6606518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IgA and IgG immune complexes in IgA nephropathy.
    Egido J; Sancho J; Rivera F; Hernando L
    Nephron; 1984; 36(1):52-9. PubMed ID: 6228743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of phenytoin treatment on IgA-containing circulating immune complexes in IgA nephropathy.
    Coppo R; Basolo B; Bulzomi MR; Piccoli G
    Nephron; 1984; 36(4):275-6. PubMed ID: 6709120
    [No Abstract]   [Full Text] [Related]  

  • 9. IgA nephropathy (Berger's disease) - a clinicopathologic study in children.
    Kher KK; Makker SP; Moorthy B
    Int J Pediatr Nephrol; 1983 Mar; 4(1):11-8. PubMed ID: 6853035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial and hereditary mesangial glomerulonephritis with IgA deposits (author's transl)].
    Gutiérrez Millet V; Navas Palacios JJ; Ortega Ruano R; Barrientos Guzmán A; Usera Sarraga G; Prieto Carles C; Montalbán MA; Rodicio JL
    Med Clin (Barc); 1981 Jan; 76(1):1-7. PubMed ID: 7012469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesangial IgA nephropathy.
    Kincaid-Smith P; Nicholls K
    Am J Kidney Dis; 1983 Sep; 3(2):90-102. PubMed ID: 6351602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mesangial IgA-glomerulonephritis].
    Rambausek M; Seelig HP; Andrassy K; Waldherr R; Kehry I; Lenhard V; Ritz E
    Dtsch Med Wochenschr; 1983 Jan; 108(4):125-30. PubMed ID: 6825588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes.
    Sancho J; Egido J; Rivera F; Hernando L
    Clin Exp Immunol; 1983 Oct; 54(1):194-202. PubMed ID: 6616968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of high polymeric IgA levels in serum of patients with Berger's disease and its modification with phenytoin treatment.
    Trascasa ML; Egido J; Sancho J; Hernando L
    Proc Eur Dial Transplant Assoc; 1979; 16():513-9. PubMed ID: 548996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic IgA nephropathy with diffuse crescent formation.
    Tang Z; Wu Y; Wang QW; Yu YS; Hu WX; Yao XD; Chen HP; Liu ZH; Li LS
    Am J Nephrol; 2002; 22(5-6):480-6. PubMed ID: 12381947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin A nephropathy complicating pulmonary tuberculosis.
    De Siati L; Paroli M; Ferri C; Muda AO; Bruno G; Barnaba V
    Ann Diagn Pathol; 1999 Oct; 3(5):300-3. PubMed ID: 10556477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.
    Nagae H; Tsuchimoto A; Tsuruya K; Kawahara S; Shimomura Y; Noguchi H; Masutani K; Katafuchi R; Kitazono T
    Clin Exp Nephrol; 2017 Apr; 21(2):266-274. PubMed ID: 27170372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.